Related Experiment Video
Updated: Aug 29, 2026

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
Published on: February 10, 2023
Phenotypic clustering in MPZ mutations
Michael E Shy1, Agnes Jáni, Karen Krajewski
1Department of Neurology, Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, Michigan, USA. m.shy@wayne.edu
Abstract:
Myelin protein zero (MPZ) is a member of the immunoglobulin gene superfamily with single extracellular, transmembrane and cytoplasmic domains. Homotypic interactions between extracellular domains of MPZ adhere adjacent myelin wraps to each other. MPZ is also necessary for myelin compaction since mice which lack MPZ develop severe dysmyelinating neuropathies in which compaction is dramatically disrupted. MPZ mutations in humans cause the inherited demyelinating neuropathy CMT1B. Some mutations cause the severe neuropathies of infancy designated as Dejerine-Sottas disease, while others cause a 'classical' Charcot-Marie-Tooth (CMT) disease Type 1B (CMT1B) phenotype with normal early milestones but development of disability during the first two decades of life. Still other mutations cause a neuropathy that presents in adults, with normal nerve conduction velocities, designated as a 'CMT2' form of CMT1B. To correlate the phenotype of patients with MPZ mutations with their genotype, we identified and evaluated 13 patients from 12 different families with eight different MPZ mutations. In addition, we re-analysed the clinical data from 64 cases of CMT1B from the literature. Contrary to our expectations, we found that most patients presented with either an early onset neuropathy with signs and symptoms prior to the onset of walking or a late onset neuropathy with signs and symptoms at around age 40 years. Only occasional patients presented with a 'classical' CMT phenotype. Correlation of specific MPZ mutations with their phenotypes demonstrated that addition of either a charged amino acid or altering a cysteine residue in the extracellular domain caused a severe early onset neuropathy. Severe neuropathy was also caused by truncation of the cytoplasmic domain or alteration of an evolutionarily conserved amino acid. Taken together, these data suggest that early onset neuropathy is caused by MPZ mutations that significantly disrupt the tertiary structure of MPZ and thus interfere with MPZ-mediated adhesion and myelin compaction. In contrast, late onset neuropathy is caused by mutations that more subtly alter myelin structure and which probably disrupt Schwann cell-axonal interactions.
Insights
Myelin protein zero (MPZ) mutations cause inherited neuropathies like CMT1B. Disruptions in MPZ structure lead to early-onset severe disease, while subtle changes cause later-onset neuropathy, impacting myelin compaction and cell interactions.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Myelin protein zero (MPZ) is crucial for myelin compaction and adhesion in the nervous system.
- Mutations in MPZ cause inherited demyelinating neuropathies, including Charcot-Marie-Tooth disease type 1B (CMT1B).
- Clinical presentations of MPZ-related neuropathies vary, ranging from early-onset severe forms to later-onset milder phenotypes.
Purpose of the Study:
- To correlate specific MPZ mutations with their resulting clinical phenotypes in patients.
- To understand the molecular mechanisms underlying the diverse presentations of MPZ-related neuropathies.
Main Methods:
- Genotypic analysis of 13 patients from 12 families with eight distinct MPZ mutations.
- Re-analysis of clinical data from 64 published CMT1B cases.
- Correlation of identified MPZ mutations with patient phenotypes.
Main Results:
- Most patients presented with either early-onset (prior to walking) or late-onset (around age 40) neuropathy, with 'classical' CMT phenotypes being less common.
- Mutations affecting the extracellular domain (charged amino acid addition, cysteine alteration) or cytoplasmic domain (truncation, conserved amino acid alteration) correlated with severe early-onset neuropathy.
- Subtle alterations in myelin structure due to specific mutations likely lead to late-onset neuropathy by disrupting Schwann cell-axonal interactions.
Conclusions:
- MPZ mutations significantly disrupting tertiary structure cause severe early-onset neuropathies by impairing myelin adhesion and compaction.
- More subtle MPZ alterations lead to late-onset neuropathies, likely through disrupted Schwann cell-axonal interactions.
- Genotype-phenotype correlations in MPZ mutations provide insights into the molecular basis of inherited demyelinating neuropathies.

